Loading company…
Mag Assist is a Suzhou, China medical device developer of short and medium-term artificial heart devices.
Based in Suzhou, China, and established in 2017, Mag Assist develops short and medium-term artificial heart devices for patients with acute cardiogenic shock, circulatory protection during cardiac surgery, and acute and severe organ failure. Its technology uses mechatronics, magnetic levitation and computational fluid dynamics. Its product pipeline includes an interventional artificial heart, an external magnetic suspension artificial heart and a new generation of extracorporeal membrane oxygenation (ECMO). The company is at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in